Genisphere's Unattributed - II Round

Genisphere raised a round of funding on October 02, 2015. Investors include Lankenau Institute for Medical Research.

Genisphere provides a DNA-based targeted drug delivery platform, called 3DNA, to deliver a variety of therapeutics including small drugs, biologics, and nucleic acids and is also advancing its own lea…

Articles about Genisphere's Unattributed - II Round: